DHRS4 and glioma: To further evaluate the role of DHRS4 in glioma cells, we performed Edu assays, which showed that the proliferation rate of cells transfected with si-DHRS4 was significantly lower than that of control cells, whereas no changes were observed when cells were cotransfected with si-DHRS4 and miR-29a-5p inhibitor (Figures 5A,B; p < 0.05, p < 0.01, respectively).